Advertisement
Research ArticleInflammation, Immunopharmacology, and Asthma

The In Vitro Pharmacology of GS-5759, A Novel Bifunctional Phosphodiesterase 4 Inhibitor and Long Acting β2-Adrenoceptor Agonist

Stacey L. Tannheimer, Eric A. Sorensen, Zhi-Hua Cui, Musong Kim, Leena Patel, William R. Baker, Gary B. Phillips, Clifford D. Wright and Michael Salmon
Journal of Pharmacology and Experimental Therapeutics April 2014, 349 (1) 85-93; DOI: https://doi.org/10.1124/jpet.113.210997
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleInflammation, Immunopharmacology, and Asthma

In Vitro Pharmacology of GS-5759

Stacey L. Tannheimer, Eric A. Sorensen, Zhi-Hua Cui, Musong Kim, Leena Patel, William R. Baker, Gary B. Phillips, Clifford D. Wright and Michael Salmon
Journal of Pharmacology and Experimental Therapeutics April 1, 2014, 349 (1) 85-93; DOI: https://doi.org/10.1124/jpet.113.210997
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement